Article Details

Newer Trials Explore High-Risk Treatment and MRD in Multiple Myeloma

Retrieved on: 2025-05-08 21:11:44

Tags for this article:

Click the tags to see associated articles and topics

Newer Trials Explore High-Risk Treatment and MRD in Multiple Myeloma. View article details on hiswai:

Excerpt

Kathleen Dorritie, MD: This study was looking at…isatuximab [Sarclisa], a CD38 monoclonal antibody ... Using Anti-CD38 Monoclonal Antibodies as ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo